Government is speaking with stakeholders to discover ambitious projects and define the role of industry in executing its recent budget proposal, which is intended to advance research and innovation in pharmaceutical industry.
ASLAN Pharmaceuticals entered into a definitive purchase agreement with BVF Partners, K2 Health Ventures, and certain existing investors to raise gross proceeds of $20 million through the sale of shares (112.3M shares equivalent to 22.5M ADSs at a...
UiPath , a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceuticals company, has turned to the UiPath Business Automation Platform to improve business operational...
Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the approval of wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for ...
RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines, and GenScript ProBio, a leading global Contract Development and Manufacturing Organization...
The asset management arm of India's Kotak Mahindra Group said it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to help it fund its acquisition of Viatris Inc's biosimilars business. In late November, Biocon Biologics completed...
Malaria No More (MNM) has signed a Memorandum of Understanding (MoU) with the Government of Odisha's Department of Health and Family Welfare to eradicate malaria from the state...
All Nippon Airways (ANA), the Japanese largest airline, and DoKaSch Temperature Solutions have signed a Master Rental Agreement. The German specialist for active temperature-controlled packaging solutions is henceforth providing its Opticooler....
The World Health Organization (WHO) has granted prequalification for the firm's varicella vaccine, Barycela, according to GC Biopharma, a leading provider of biopharmaceutical products in South Korea...
Gland Pharma announced today that it will invest Rs 400 crore to expand its existing facility in Genome Valley here to manufacture biologicals, biosimilars, antibodies, and recombinant insulin. According to a state government press release, the...
, CDSCO.jpg)
